Table 1 Demographic characteristics of the patients in Fudan cohort and CPTAC cohort
From: Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
Variable | Fudan cohort (n = 229) | CPTAC cohort (n = 140) |
|---|---|---|
Participant area | Â | Â |
 East Asia | 229 (100%) | 21 (15%) |
 Europe | 0 | 60 (43%) |
 America | 0 | 47 (34%) |
 Other | 0 | 12 (9%) |
Sex | Â | Â |
 Male | 133 (58%) | 74 (53%) |
 Female | 96 (42%) | 66 (47%) |
Age | Â | Â |
 ≤ 60 | 89 (39%) | 40 (29%) |
 > 60 | 140 (61%) | 100 (71%) |
TNM stage **** | Â | Â |
 IA | 28 (12%) | 7 (5%) |
 IB | 77 (34%) | 16 (11%) |
 IIA | 16 (7%) | 8 (6%) |
 IIB | 89 (39%) | 52 (37%) |
 III | 19 (8%) | 42 (30%) |
  IV | 0 | 9 (7%) |
 Not sure | 0 | 6 (4%) |
Location | Â | Â |
 Pancreaticoduodenum | 145 (63%) | 105 (75%) |
 Pancreatic body and tail | 84 (37%) | 33 (24%) |
 Not sure | 0 | 2 (1%) |
History of diabetes | Â | Â |
 Yes | 44 (19%) | 39 (28%) |
 No | 183 (80%) | 101 (72%) |
 Not sure | 2 (1%) | 0 |
Metastasis (follow-up) | Â | Â |
 Yes | 93 (40%) | NA |
 No | 68 (30%) | NA |
 Not sure | 68 (30%) | NA |